Positive impact of clinical pharmacist interventions on antipsychotic use in patients on excessive polypharmacy evidenced in a retrospective cohort study
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8:151–7.BallardCHanneyMLTheodoulouMDouglasSMcShaneRKossakowskiKet alThe dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial20098151–710.1016/S1474-4422(08)70295-3Search in Google Scholar
Beovic B, Plesnicar BK, Potocan M. Antibiotic prescribing in psychiatric hospitals and interactions between antibiotics and psychotropic drugs: a prospective observational study. Infect Control Hosp Epidemiol. 2016;37:233–235. doi: 10.1017/ ice.2015.268.BeovicBPlesnicarBKPotocanMAntibiotic prescribing in psychiatric hospitals and interactions between antibiotics and psychotropic drugs: a prospective observational study201637233–23510.1017/ice.2015.268Open DOISearch in Google Scholar
Centorrino F, Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits. Am J Psychiatry. 2004;161:700–6.CentorrinoFGorenJLHennenJSalvatorePKelleherJPBaldessariniRJMultiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits2004161700–610.1176/appi.ajp.161.4.700Search in Google Scholar
Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta analysis. Lancet. 2009;373:746–58.CiprianiAFurukawaTASalantiGGeddesJRHigginsJPChurchillRet alComparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta analysis2009373746–5810.1016/S0140-6736(09)60046-5Search in Google Scholar
Goodwin G, Fleischhacker W, Arango C, Baumann P, Davidson M, de Hert M, et al. Advantages and disadvantages of combination treatment with antipsychotics, ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol. 2009;19:520–532.GoodwinGFleischhackerWArangoCBaumannPDavidsonMde HertMet alAdvantages and disadvantages of combination treatment with antipsychotics, ECNP Consensus Meeting, March 2008, Nice200919520–53210.1016/j.euroneuro.2009.04.00319411165Search in Google Scholar
Gören JL, Beck SE, Mills BJ, Shtasel DL, Dufresne RL. Development and delivery of a quality improvement program to reduce antipsychotic polytherapy. J Manag Care Pharm. 2010;16:393–401.GörenJLBeckSEMillsBJShtaselDLDufresneRLDevelopment and delivery of a quality improvement program to reduce antipsychotic polytherapy201016393–40110.18553/jmcp.2010.16.6.39320635830Search in Google Scholar
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, et al. World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World Federation of Societies of Biological Psychiatry (WFSBP). World J Biol Psychiatry. 2012;13:318–378.HasanAFalkaiPWobrockTLiebermanJGlenthojBGattazWFet alWorld Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia. Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance201213318–37810.3109/15622975.2012.69614322834451Search in Google Scholar
Hashimoto Y, Tensho M. Effect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study. BMC Health Serv Res. 2016;26;16:150.HashimotoYTenshoMEffect of pharmacist intervention on physician prescribing in patients with chronic schizophrenia: a descriptive pre/post study2016261615010.1186/s12913-016-1408-4484719027117589Search in Google Scholar
Hazra M, Uchida H, Sproule B, Remington G, Suzuki T, Mamo DC. Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia. Psychiatry Clin Neurosci. 2011;65:676–8.HazraMUchidaHSprouleBRemingtonGSuzukiTMamoDCImpact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia201165676–810.1111/j.1440-1819.2011.02280.x22176287Search in Google Scholar
Heun R. How to write a scientific paper: A hypothesis-based approach. Global Psychiatry. 2018;1(1):3-6. doi: https://doi.org/10.2478/gp-2018–0004HeunRHow to write a scientific paper: A hypothesis-based approach2018113–6https://doi.org/10.2478/gp-2018–000410.2478/gp-2018-0004Search in Google Scholar
Holt S, Schmiedl S, Thürmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107:543–51.HoltSSchmiedlSThürmannPAPotentially inappropriate medications in the elderly: the PRISCUS list2010107543–51Search in Google Scholar
Holzapfel E, Szabo C. Pharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population. Global Psychiatry. 2018;1(2):39-51. doi: https://doi.org/10.2478/gp-2018-0006HolzapfelESzaboCPharmacotherapy prescribing patterns in the treatment of bipolar disorder in a South African outpatient population20181239–51https://doi.org/10.2478/gp-2018-000610.2478/gp-2018-0006Search in Google Scholar
Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, et al. Clozapine alone versus clozapine and risperidone with refractory schizophrenia. N Engl J Med. 2006;354:472–82.HonerWGThorntonAEChenEYChanRCWongJOBergmannAet alClozapine alone versus clozapine and risperidone with refractory schizophrenia2006354472–8210.1056/NEJMoa05322216452559Search in Google Scholar
Howes OD, Vergunst F, Gee S, McGuire P, Kapur S, Taylor D. Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation, Br J Psychiatry. 2012;201:481–485.HowesODVergunstFGeeSMcGuirePKapurSTaylorD2012201481–48510.1192/bjp.bp.111.10583322955007Search in Google Scholar
Krause M, Huhn M, Schneider-Thoma J, Rothe P, Smith RC, Leucht S. Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis. Eur Neuropsychopharmacol. 2018;28(12):1360–1370.KrauseMHuhnMSchneider-ThomaJRothePSmithRCLeuchtSAntipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis201828121360–137010.1016/j.euroneuro.2018.09.00730243680Search in Google Scholar
Lexicomp® drug-drug interaction checker. Accessed October 10, 2017: https://www.uptodate.comAccessed October 102017https://www.uptodate.comSearch in Google Scholar
Mann E, Haastert B, Böhmdorfer B, Frühwald T, Iglseder B, Roller-Wirnsberger R, et al. Prevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study. Wien Klin Wochenschr. 2013;125:180–188.MannEHaastertBBöhmdorferBFrühwaldTIglsederBRoller-WirnsbergerRet alPrevalence and associations of potentially inappropriate prescriptions in Austrian nursing home residents: secondary analysis of a cross-sectional study2013125180–18810.1007/s00508-013-0342-223536016Search in Google Scholar
Marušič Premuš A. Pharmacotherapy reviews in hospitals and at an outpatient clinic Farmakoterapijski pregledi v bolnišnicah in v ambulantah – izkušnje in evalvacija dela. Farmacevtski vestnik. 2014;65:187–190.MarušičPremuš A.Pharmacotherapy reviews in hospitals and at an outpatient clinic Farmakoterapijski pregledi v bolnišnicah in v ambulantah – izkušnje in evalvacija dela201465187–190Search in Google Scholar
Meesters PD, de Haan L, Comijs HC, Stek ML, Smeets-Janssen MM, Weeda MR, et al. Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment area. Am J Geriatr Psychiatry. 2012;20:18–28.MeestersPDde HaanLComijsHCStekMLSmeets-JanssenMMWeedaMRet alSchizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a dutch catchment area20122018–2810.1097/JGP.0b013e3182011b7f22183010Search in Google Scholar
O’Dwyer M, Peklar J, McCallion P, McCarron M, Henman MC. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open. 2016;6(4):e010505.O’DwyerMPeklarJMcCallionPMcCarronMHenmanMCFactors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study201664e01050510.1136/bmjopen-2015-010505482345827044582Search in Google Scholar
Quality and Outwork framework 2012 (Accessed on 27 of January 2018): https://www.nhsemployers.org/2012(Accessed on 27 of January 2018)https://www.nhsemployers.org/Search in Google Scholar
Rieckert A, Trampisch US, Klaaßen-Mielke R, Drewelow E, Esmail A, Johansson T, et al. Polypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy. BMC Fam Pract. 2018;19(1):113. doi: 10.1186/s12875-018-0795-5.RieckertATrampischUSKlaaßen-MielkeRDrewelowEEsmailAJohanssonTet alPolypharmacy in older patients with chronic diseases: a cross-sectional analysis of factors associated with excessive polypharmacy201819111310.1186/s12875-018-0795-5605259230021528Open DOISearch in Google Scholar
Schumacher JE, Makela EH, Griffin HR. Multiple antipsychotic medication prescribing patterns. Ann Pharmacother. 2003;37:951– 5.SchumacherJEMakelaEHGriffinHRMultiple antipsychotic medication prescribing patterns200337951–95510.1345/aph.1C42012841799Search in Google Scholar
Stahl SM. Emerging guidelines for the use of antipsychotic polypharmacy. Rev Psiquiatr Salud Ment. 2013;6:97–100.StahlSMEmerging guidelines for the use of antipsychotic polypharmacy2013697–10010.1016/j.rpsmen.2013.01.001Search in Google Scholar
Stuhec M, Gorenc K, Zelko E. Evaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation. BMC Health Serv Res. 2019;19(1):118.StuhecMGorencKZelkoEEvaluation of a collaborative care approach between general practitioners and clinical pharmacists in primary care community settings in elderly patients on polypharmacy in Slovenia: a cohort retrospective study reveals positive evidence for implementation201919111810.1186/s12913-019-3942-3Search in Google Scholar
Stuhec M, Serra-Mestres J. Antidepressant drugs for older patients on polypharmacy: a systematic review reveals best evidence for sertraline, Global Psychiatry. 2018;1(1):17–24. doi: https://doi.org/10.2478/gp-2018-0005StuhecMSerra-MestresJ20181117–24https://doi.org/10.2478/gp-2018-000510.2478/gp-2018-0005Search in Google Scholar
Stuhec M. Pharmacotherapy review as a safety and cost tool in patients management in Slovenian Psychiatric Hospital. V: Abstracts of the 27th ECNP Congress, Berlin, Germany, 18-21 October 2014. European Neuropsychopharmacology. 2014;24:S735–S736.StuhecMPharmacotherapy review as a safety and cost tool in patients management in Slovenian Psychiatric Hospital. V: Abstracts of the 27th ECNP Congress, Berlin, Germany, 18-21 October 2014201424S735–S73610.1016/S0924-977X(14)71185-XSearch in Google Scholar
Stuhec M, Gorenc K. Clinical pharmacist interventions in elderly patients in primary care treated with polypharmacy and psychotropics: Observational retrospective study. European Neuropsychopharmacology. 2019;29:S545–S546StuhecMGorencKClinical pharmacist interventions in elderly patients in primary care treated with polypharmacy and psychotropics: Observational retrospective study201929S545–S54610.1016/j.euroneuro.2018.11.805Search in Google Scholar
Summary of Product Characteristics (SmPC) of sulpiride. Accessed October 10, 2017: https://www.medicines.org.uk/emc/product/2430/smpcAccessed October 102017https://www.medicines.org.uk/emc/product/2430/smpcSearch in Google Scholar
Suzuki T, Uchida H, Watanabe K, Yagi G, Kashima H. A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28(2):361–9.SuzukiTUchidaHWatanabeKYagiGKashimaHA clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia2004282361–910.1016/j.pnpbp.2003.11.00614751434Search in Google Scholar
Taylor DM, Young C, Paton C. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review. J Clin Psychiatry. 2003;64:30–34.TaylorDMYoungCPatonCPrior antipsychotic prescribing in patients currently receiving clozapine: a case note review20036430–3410.4088/JCP.v64n010712590620Search in Google Scholar
Tiihonen J, Taipale H, Mehtälä J, Vattulainen P, Correll CU, Tanskanen A. Association of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia. JAMA Psychiatry. 2019 Feb 20. doi: 10.1001/ jamapsychiatry.2018.4320.TiihonenJTaipaleHMehtäläJVattulainenPCorrellCUTanskanenAAssociation of Antipsychotic Polypharmacy vs Monotherapy With Psychiatric Rehospitalization Among Adults With Schizophrenia2019Feb 20. doi10.1001/jamapsychiatry.2018.4320649535430785608Open DOISearch in Google Scholar
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–49.von ElmEAltmanDGEggerMPocockSJGøtzschePCVandenbrouckeJPSTROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies2008614344–4910.1016/j.jclinepi.2007.11.00818313558Search in Google Scholar
Wilson SJ. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24:1577–601.WilsonSJBritish Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders2010241577–60110.1177/026988111037930720813762Search in Google Scholar